Evidence map›Paper›PMID 41931560›Full record

ArticlePloS one2026

Enhancement of RecET-mediated in vivo linear DNA assembly by a xonA mutation.

James A Sawitzke, Nina Costantino, Adriana Castillo Caballero, Ellen Hutchinson, Alessandro Barenghi, Lynn C Thomason, Donald L Court

Abstract read
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Recombineering in Non-Model Bacteria.Current protocols · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

James A SawitzkeGenetic & Viral Engineering Facility, Epigenetics and Neurobiology Unit, European Molecular Biology Laboratory, Monterotondo (RM), Italy.ORCID https://orcid.org/0000-0002-4873-3081
Nina CostantinoGene Regulation and Chromosome Biology Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.
Adriana Castillo CaballeroGenetic & Viral Engineering Facility, Epigenetics and Neurobiology Unit, European Molecular Biology Laboratory, Monterotondo (RM), Italy.
Ellen HutchinsonGene Regulation and Chromosome Biology Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.
Alessandro BarenghiGenetic & Viral Engineering Facility, Epigenetics and Neurobiology Unit, European Molecular Biology Laboratory, Monterotondo (RM), Italy.
Lynn C ThomasonGene Regulation and Chromosome Biology Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.
Donald L CourtGene Regulation and Chromosome Biology Laboratory, Frederick National Laboratory for Cancer Research, National Cancer Institute, Frederick, Maryland, United States of America.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Assembly of intact, replicating plasmids from linear DNA fragments introduced into bacterial cells, i.e., in vivo cloning, is a facile genetic engineering technology that avoids many of the problems associated with standard in vitro cloning. Here, we report characterization of various parameters of in vivo linear DNA assembly mediated by either the RecET recombination system or the bacteriophage λ Red recombination system. As previously observed, RecET is superior to Red for this reaction when the terminal homology is 50 bases. Deletion of the E. coli xonA gene, encoding Exonuclease I, a 3' → 5' single-strand DNA exonuclease, substantially improves the efficiency of in vivo linear DNA assembly for both systems. Deletion of the Exonuclease I function allows robust RecET assembly of six DNA segments to create a functional plasmid. The linear DNAs are joined accurately with very few errors. This activity is at least as efficient and accurate as the NEBuilder® HiFi DNA Assembly in vitro method of assembling fragments. This discovery provides a significant improvement to previously reported in vivo linear DNA assembly technologies and provides a faster, less expensive, one-step method for assembling plasmids from multiple fragments.

Indexed as

DNAEscherichia coliEscherichia coli ProteinsExodeoxyribonucleasesMutationBacteriophage lambdaPlasmidsRecombination, GeneticDNAEscherichia coli Proteinsexodeoxyribonuclease IExodeoxyribonucleases

Identifiers

PMID41931560
PMCPMC13048471

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.